Pharmacological Management of Hypertension in Type 2 Diabetic Patients: Drug Selection, Treatment Guidelines, Interactions, and Safety
Keywords:
Alcohol Consumption, Alcoholic Liver Disease, Alcoholic Hepatitis, Steatosis, Fibrosis, Biomarkers, Pathogenesis, Management, PreventionAbstract
Alcohol consumption is a major global determinant of liver disease, spanning a spectrum from reversible steatosis to progressive fibrosis, cirrhosis, and hepatocellular carcinoma. The relationship between the amount, pattern, and duration of alcohol exposure and liver injury is influenced by host genetics, comorbid metabolic disease, nutritional status, gut–liver axis perturbations, and coexisting hepatic insults such as viral hepatitis. This review synthesizes current knowledge on epidemiology, pathophysiology, clinical presentation, diagnostic biomarkers, management strategies, and prevention approaches for alcohol-related liver injury. It highlights mechanisms-including ethanol metabolism, oxidative stress, immune activation, and fibrogenesis-that mediate hepatocellular damage and examines modifiers that shape individual susceptibility. Finally, we outline evidence-based clinical approaches and gaps that require future research.
Downloads
References
Griswold MG, Fullman N, Hawley C, Arian N, Zimsen SRM, Tymeson HD, et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10152):1015–35.
World Health Organization. Global status report on alcohol and health 2018. Geneva: WHO; 2018.
Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373(9682):2223–33.
Rehm J, Shield KD. Global burden of disease and the impact of alcohol. Biomedicines. 2019;7(4):99.
National Institute on Alcohol Abuse and Alcoholism (NIAAA). Surveillance Report #118: Apparent Per Capita Alcohol Consumption: National, State, and Regional Trends, 1977–2019. Bethesda (MD): NIAAA; 2020.
Stickel F, Hampe J. Genetic determinants of alcoholic liver disease. Gut Liver. 2017;11(2):173–87.
Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol‐associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;72(1):31–64.
Thursz MR, Kamath PS, Mathurin P, Szabo G, Shah VH. Alcohol-related liver disease: areas of consensus, unmet needs and opportunities for further study. J Hepatol. 2018;69(1):154–88.
Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. Addiction. 2010;105(5):817–43.
Kale SR. Diabetes associated complicated disorders and its treatment a review article. World Journal of Current Medical and Pharmaceutical Research. 2023 Jul 22:99-106.
Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health. 2006;29(4):245–54.
Zeng T, Zhang CL, Song FY, Zhao XL, Xie KQ. Molecular mechanisms of hepatotoxicity induced by alcohol: oxidative stress and mitochondrial dysfunction (Review). J Immunol Res. 2016;2016:1–9.
KOTHA P, Vasabhakthula NV, Undurthi C. A study on the effect of exacerbations on the quality of life of patients with chronic obstructive pulmonary disease. World Journal of Current Medical and Pharmaceutical Research. 2020 Dec 15:319-21.
Malnick SDH, Alin P, Katan MB, Levi Z. Alcohol, gut microbiome and liver: The role of the gut–liver axis in the pathogenesis of alcohol-related liver disease. Front Med (Lausanne). 2022;9:9783455.
Idalsoaga F, Kulkarni AV, Mousa OY, Arrese M, Arab JP. Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. Front Med (Lausanne). 2020;7:448.
Tom AA, Antony N, Ashok P, PS MA, Jojo J. Assessment of patient knowledge, practice and adverse events of insulin administration and storage techniques in patients with diabetes. Journal of Innovations in Applied Pharmaceutical Science (JIAPS). 2023 Nov 30:42-6.
Shield KD, Parry C, Rehm J. Chronic diseases and conditions related to alcohol use. Addiction. 2013;108(6):989–1000.
Northcote J, Livingston M. Accuracy of self-reported drinking: observational study of differences between self-reported and actual alcohol consumption. Alcohol Alcohol. 2011;46(5):593–6.
Stickel F, Buch S, Lau K, Meyer C, Berg T, Ridinger M, et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver disease. Semin Liver Dis. 2015;35(2):170–92.
Chayanupatkul M, Liangpunsakul S. Alcoholic liver disease: Clinical aspects and treatment. World J Gastroenterol. 2014;20(44):15563–75.
European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70(1):172–93.
Kaur M, Barwal A, Kumari S, Atteri S. Diabetes Mellitus: An Incisive Review. International Journal of Pharmaceutics and Drug Analysis.;4(11):494-504.
Peterson KP. Alcohol biomarkers: clinical utility and limitations. Ann Clin Biochem. 2004;41(Pt 6):116–27.
ARUP Laboratories. Alcohol Use Biomarkers: Choose the Right Test. Salt Lake City (UT): ARUP Consult; 2024.
Poojitha D, Narendra JB. Prevalence of comorbidities associated with COVID19 in andhra pradesh, India. International Journal of Pharmaceutics and Drug Analysis. 2020;8(10):1-4.
Basu VR, Shanthi G, Shirisha A. A review on recent trends of diabetes mellitus. Journal of Innovations in Applied Pharmaceutical Science (JIAPS). 2022 Jan 6:01-9.
Bryazka D, Reitsma MB, Griswold MG, et al. Population-level patterns of liver disease mortality attributable to alcohol use. Lancet Public Health. 2022;7(8):e633–43.
Mackowiak B, Mellinger JL, Hines IN. Alcohol and metabolic-associated fatty liver disease: interactions and implications. Clin Liver Dis (Hoboken). 2024;23(1):1–10.
World Health Organization. Recommendations for screening and brief interventions for hazardous and harmful alcohol use. Geneva: WHO; 2017.
Raju AK. Newer Insights of Relationship between Obesity and Pregnancy Complications-a single Centered Prospective Study. World Journal of Current Medical and Pharmaceutical Research. 2023 Jul 21:94-8.
Mathurin P, Louvet A, Duhamel A, Nahon P, Carbonell N, Boursier J, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;365(4):403–11.
32.Thursz M, Gual A, Lackner C. Treatment and prognosis of alcoholic hepatitis. Gastroenterology. 2016;150(1):183–94.
Shanmugam H, Liu Y, Sheth D, et al. Emerging therapies in alcohol-associated liver disease. Hepatology. 2022;76(3):1034–49.
Vyshnavi P, Venkatesh P. Review on diabetes mellitus. Journal of Innovations in Applied Pharmaceutical Science (JIAPS). 2022 Jan 26:24-7.
Saberi B, Dadabhai AS, Jang YY, Mezey E. Advances in clinical management of alcoholic liver disease. J Clin Transl Hepatol. 2016;4(3):206–15.
Khan A, Sheron N, Anand AC. Emerging and experimental therapies in alcoholic hepatitis. Clin Liver Dis. 2021;25(4):829–48.
World Health Organization. Cancer warning labels and stronger alcohol policy action: policy brief. Geneva: WHO; 2025.
AL-Habsi KA, AL-Mahdouri HN, Amaresh N, Mullaicharam AR. Retrospective Study on Diabetes Patients in Two Different Regions in Oman. International Journal of Pharmaceutics and Drug Analysis.;3(4):91-7.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
(CC BY-NC)
.